Genmab A/S Stock

Genmab A/S P/TBV

The Price to Tangible Book Value (P/TBV) of Genmab A/S (GMAB.CO) as of Aug 2, 2026 is -4.61. In the previous year, Price to Tangible Book Value (P/TBV) was 5.52 — a change of -183.43% (lower).

P/TBV

-4.61

YoY

-183.43%

Last updated:

Price to Tangible Book Value (P/TBV) of Genmab A/S is 2026 -4.61 . Price to Tangible Book Value (P/TBV) of Genmab A/S was 2025 5.52 . It decreases by -183.43% lower compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Price to Tangible Book Value (P/TBV) of Genmab A/S is -4.61 in 2026.

Access this data via the Eulerpool API

Valuation — Genmab A/S

All Key Metrics — Genmab A/S